Flexion Therapeutics Inc. (FLXN)
Symbol Info
Listed Symbol FLXN
Name Flexion Therapeutics Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $22,524,000
Latest Fiscal EPS $-4.48
Price Info
21 Day Moving Average $13.9657
21 Day EMA $13.805830
50 Day Moving Average $13.1384
50 Day EMA $13.207320
200 Day EMA $13.399070
200 Day Moving Average 12.342550
52 Week High $19.36
52 Week Low $8.76
52 Week Change $-23.564100
Alpha 0.002476
Beta 1.3140
Standard Deviation 0.187287
R2 0.058051
Periods 60
Share Information
10 Day Average Volume 573,978
20 Day Average Volume 582,334
30 Day Average Volume 590,878
50 Day Average Volume 591,106
Outstanding Shares 38,106,641
Float Shares 37,541,068
Percent Float 98.52%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 302
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 3,540,436
Institute Holdings Percent -
Institute Sold Previous 3 Months 3,424,556
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months 19
Insider Holdings Percent 1.50%
Insider Sold Previous 3 Months -
Insiders Shares Owned 565,573
Price Change
7 Day Price Change $0.8800001
7 Day Percent Change 6.59%
21 Day Price Change $0.3299999
21 Day Percent Change 2.37%
30 Day Price Change $-0.3000002
30 Day Percent Change -2.06%
Month To Date Price Change $0.5350
Month To Date Percent 3.90%
90 Day Price Change $3.320000
90 Day Percent Change 30.40%
Quarter To Date $0.535000
Quarter To Date Percent 3.90%
180 Day Price Change $4.020000
180 Day Percent Change 39.33%
200 Day Price Change $1.820000
200 Day Percent Change 14.65%
Year To Date $2.920000
Year To Date Percent 25.80%
Profile
Description Flexion Therapeutics Inc is a United States-based specialty pharmaceutical company. The company focuses on the development and commercialization of novel, local therapies. The company specializes in the treatment of patients with musculoskeletal conditions beginning with osteoarthritis. The products offered by company are zilretta which is used for enhancing clinical effect of intra articular corticosteroid treatment.
Details
Issue Type CS
Market Cap $542,638,568
Sec Type EQS
Auditor PricewaterhouseCoopers LLP
Total Shares Outstanding 38,106,641
CEO Michael D. Clayman
Employees 272
Last Audit UQ
Classification
CIK 0001419600
Industry Drug Manufacturers
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 10 Mall Road
Suite 301
Burlington, MA 1803
Website http://www.flexiontherapeutics.com
Facisimile +1 781 202-3399
Telephone +1 781 305-7777
Email syoung@flexiontherapeutics.com
Key Ratios
Profitability
EBIT Margin -332.5
EBITDA Margin -328.8
Pre-Tax Profit Margin -
Profit Margin Cont -
Gross Margin 84.40
Profit Margin TOT -
Income Statements
Revenue $37,060,000
Revenue Per Share $0.9725
Revenue 3 Years $-
Revenue 5 Years $-
Valuation Measures
PE Ratio -
Enterprise Value $515,674,514
Price To Sales 14.642162
Price To Free Cash -4
PE High Last 5 Years -
Price To Book 11.8
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 11.8
Financial Strength
Total Debt To Equity 4.0
Int Coverage -9.3
Current Ratio 7.8
Leverage Ratio 5.9
Quick Ratio 7.2
Long Term Debt To Capital 0.80
Assets
Receivables Turnover 1.7
Invoice Turnover 0.80
Assets Turnover -
Management Effectiveness
Return Assets -54.53
Return On Equity -142.96
Return On Capital -54.61
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
FLXN
Flexion Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.